CD8A and ovarian cancer: Cisplatin-resistant ovarian cancer cells secrete exosomes carrying plasma gelsolin (pGSN), which induce CD8(+) T lymphocyte apoptosis, decrease IFN-γ secretion, and increase the glutathione (GSH) content in ovarian cancer cells, enhancing immune resistance [86].